Max S. Mano
0000-0001-5666-5261
Publication & Citation Trends
Publications
268 total
Survival with Trastuzumab Emtansine in Residual HER2-Positive Breast Cancer.
Cited by 68
Semantic Scholar
Treatment with trastuzumab for 1 year after adjuvant chemotherapy in patients with HER2-positive early breast cancer: a 4-year follow-up of a randomised controlled trial
Cited by 611
OpenAlex
Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12 155 patients PDF
Cited by 957
OpenAlex
Remaining controversies in the upfront management of advanced ovarian cancer
Cited by 18
Semantic Scholar
Second malignancies following adjuvant chemotherapy: 6-year results from a Belgian randomized study comparing cyclophosphamide, methotrexate and 5-fluorouracil (CMF) with an anthracycline-based regimen in adjuvant treatment of node-positive breast cancer patients. OA
Cited by 55
Semantic Scholar
Research Topics
Breast Cancer Treatment Studies
(118)
HER2/EGFR in Cancer Research
(92)
Cancer Treatment and Pharmacology
(41)
Advanced Breast Cancer Therapies
(33)
Cancer Cells and Metastasis
(25)
Affiliations
Goethe University Frankfurt
Ulsan College
Thiruvalluvar University
Roche (Switzerland)
Novartis (Switzerland)